Banexi Ventures is the famous VC, which was founded in 1983. The venture was found in Europe in France. The main office of represented VC is situated in the Paris.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Banexi Ventures, startups are often financed by BioMedPartners, Sofinnova Partners, Orkos Capital. The meaningful sponsors for the fund in investment in the same round are Innovacom, Orkos Capital, Innovation Capital. In the next rounds fund is usually obtained by Sigma Gestion, Endeavour Vision, CDC Enterprises.
The fund has no exact preference in some founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are E-Commerce, Retail. For fund there is a match between the location of its establishment and the land of its numerous investments - France. Among the most popular portfolio startups of the fund, we may highlight Kelkoo, ScreenCell, Mobibase.
The increased amount of exits for fund were in 2017. The fund is constantly included in less than 2 deals per year. The important activity for fund was in 2015. Comparing to the other companies, this Banexi Ventures performs on 8 percentage points less the average number of lead investments. Deals in the range of 5 - 10 millions dollars are the general things for fund. Considering the real fund results, this VC is 3 percentage points more often commits exit comparing to other organizations.
Besides them, we counted 3 critical employees of this fund in our database.
Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Aleva Neurotherapeutics | $18M | 27 May 2016 | Lausanne, Vaud, Switzerland | ||
Innovorder | $472K | 30 Oct 2015 | Ile-de-France | ||
Dolmen | $5M | 24 Jul 2015 | Brittany | ||
Reevoo | $1M | 18 Mar 2015 | London, England, United Kingdom | ||
FittingBox | $2M | 14 May 2014 | Auvergne-Rhône-Alpes | ||
Linkfluence | $4M | 07 Mar 2014 | Oslo, Norway | ||
Linkfluence | $4M | 12 Sep 2013 | Oslo, Norway | ||
ADYOULIKE | $1M | 31 Jan 2013 | New York, United States | ||
Aleva Neurotherapeutics | $4M | 10 Apr 2012 | Lausanne, Vaud, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Aleva Neurotherapeutics | $18M | 27 May 2016 | Lausanne, Vaud, Switzerland | ||
Innovorder | $472K | 30 Oct 2015 | Ile-de-France | ||
Dolmen | $5M | 24 Jul 2015 | Brittany | ||
Reevoo | $1M | 18 Mar 2015 | London, England, United Kingdom | ||
FittingBox | $2M | 14 May 2014 | Auvergne-Rhône-Alpes | ||
Linkfluence | $4M | 07 Mar 2014 | Oslo, Norway | ||
Linkfluence | $4M | 12 Sep 2013 | Oslo, Norway | ||
ADYOULIKE | $1M | 31 Jan 2013 | New York, United States | ||
Aleva Neurotherapeutics | $4M | 10 Apr 2012 | Lausanne, Vaud, Switzerland |